Skip to content
10-Q

Quarterly Report

VIGIL NEUROSCIENCE, INC.

0000950170-24-095755

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 31, 2024 39.65M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $10.76M
Current Liabilities Q2 2024 · Dec 31, 2023 $11.66M
Total Liabilities Q2 2024 · Jun 30, 2024 $23.19M
Total Liabilities Q2 2024 · Dec 31, 2023 $24.61M
Current Assets Q2 2024 · Jun 30, 2024 $90.22M
Current Assets Q2 2024 · Dec 31, 2023 $121.91M
Total Assets Q2 2024 · Jun 30, 2024 $108.46M
Total Assets Q2 2024 · Dec 31, 2023 $140.86M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $51.99M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $58.74M
Shares Diluted Q2 2024 · Jun 30, 2023 38.66M sh
Shares Diluted Q2 2024 · Jun 30, 2023 38.6M sh
Capex Q2 2024 · Jun 30, 2023 $614K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$37.54M
Stockholders Equity Q2 2024 · Jun 30, 2023 $153.84M
Stockholders Equity Q2 2024 · Mar 31, 2023 $171.34M
Stockholders Equity Q2 2024 · Dec 31, 2022 $189.08M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.52
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.04
Eps Basic Q2 2024 · Jun 30, 2023 −$0.52
Eps Basic Q2 2024 · Jun 30, 2023 −$1.04
Sga Expense Q2 2024 · Jun 30, 2023 $7.01M
Sga Expense Q2 2024 · Jun 30, 2023 $13.95M
Rd Expense Q2 2024 · Jun 30, 2023 $14.9M
Rd Expense Q2 2024 · Jun 30, 2023 $28.74M
Net Income Q2 2024 · Jun 30, 2023 −$20.17M
Net Income Q2 2024 · Jun 30, 2023 −$39.97M
Net Income Q2 2024 · Mar 31, 2023 −$19.8M
Operating Income Q2 2024 · Jun 30, 2023 −$21.91M
Operating Income Q2 2024 · Jun 30, 2023 −$42.69M